Please use this identifier to cite or link to this item: https://doi.org/10.1038/ncomms8203
Title: Developmental-stage-dependent transcriptional response to leukaemic oncogene expression
Authors: Regha, K 
Assi, S.A
Tsoulaki, O
Gilmour, J
Lacaud, G
Bonifer, C
Keywords: hybrid protein
RUNX1 ETO protein
transcription factor RUNX1
unclassified drug
DNA binding protein
messenger RNA
MTG8 protein, mouse
oncoprotein
Runx1 protein, mouse
transcription factor
transcription factor RUNX1
transcriptome
blood
developmental stage
gene expression
genetic differentiation
germ cell
molecular analysis
acute myeloblastic leukemia
animal cell
Article
binding site
blood cell
cell differentiation
cell expansion
cell population
cell selection
chromatin immunoprecipitation
controlled study
developmental stage
down regulation
embryo
embryonic stem cell
flow cytometry
gene expression
gene repression
genetic transcription
hemangioblast
hematopoietic cell
hematopoietic stem cell
human
human cell
in vitro study
leukemogenesis
mouse
multipotent stem cell
myeloid progenitor cell
myelopoiesis
nonhuman
oncogene
phenotype
protein binding
protein induction
target cell
upregulation
acute myeloid leukemia
animal
cell culture technique
cytology
electroporation
gene expression regulation
gene regulatory network
gene translocation
genetics
hematopoiesis
metabolism
mouse embryonic stem cell
Western blotting
Animals
Blotting, Western
Cell Culture Techniques
Chromatin Immunoprecipitation
Core Binding Factor Alpha 2 Subunit
DNA-Binding Proteins
Electroporation
Flow Cytometry
Gene Expression Regulation, Developmental
Gene Expression Regulation, Neoplastic
Gene Regulatory Networks
Hematopoiesis
In Vitro Techniques
Leukemia, Myeloid, Acute
Mice
Mouse Embryonic Stem Cells
Oncogene Proteins, Fusion
Proto-Oncogene Proteins
RNA, Messenger
Transcription Factors
Transcriptome
Translocation, Genetic
Issue Date: 2015
Publisher: Nature Publishing Group
Citation: Regha, K, Assi, S.A, Tsoulaki, O, Gilmour, J, Lacaud, G, Bonifer, C (2015). Developmental-stage-dependent transcriptional response to leukaemic oncogene expression. Nature Communications 6 : 7203. ScholarBank@NUS Repository. https://doi.org/10.1038/ncomms8203
Rights: Attribution 4.0 International
Abstract: Acute myeloid leukaemia (AML) is characterized by a block in myeloid differentiation the stage of which is dependent on the nature of the transforming oncogene and the developmental stage of the oncogenic hit. This is also true for the t(8;21) translocation that gives rise to the RUNX1-ETO fusion protein and initiates the most common form of human AML. Here we study the differentiation of mouse embryonic stem cells expressing an inducible RUNX1-ETO gene into blood cells as a model, combined with genome-wide analyses of transcription factor binding and gene expression. RUNX1-ETO interferes with both the activating and repressive function of its normal counterpart, RUNX1, at early and late stages of blood cell development. However, the response of the transcriptional network to RUNX1-ETO expression is developmental stage specific, highlighting the molecular mechanisms determining specific target cell expansion after an oncogenic hit. © 2015 Macmillan Publishers Limited. All rights reserved.
Source Title: Nature Communications
URI: https://scholarbank.nus.edu.sg/handle/10635/180469
ISSN: 2041-1723
DOI: 10.1038/ncomms8203
Rights: Attribution 4.0 International
Appears in Collections:Elements
Staff Publications

Show full item record
Files in This Item:
File Description SizeFormatAccess SettingsVersion 
10_1038_ncomms8203.pdf2.04 MBAdobe PDF

OPEN

NoneView/Download

Google ScholarTM

Check

Altmetric


This item is licensed under a Creative Commons License Creative Commons